Canadian Pharmaceuticals & Biotech High Insider Buying

Aurora Cannabis

Market Cap: CA$419.5m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Eupraxia Pharmaceuticals

Market Cap: CA$260.3m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Auxly Cannabis Group

Market Cap: CA$228.5m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

HLS Therapeutics

Market Cap: CA$159.8m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

Oncolytics Biotech

Market Cap: CA$140.5m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

Quantum BioPharma

Market Cap: CA$119.2m

Operates as a biopharmaceutical company.

ME Therapeutics Holdings

Market Cap: CA$118.4m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Atlas Energy

Market Cap: CA$113.3m

A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

TRUBAR

Market Cap: CA$99.1m

Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.

Helix BioPharma

Market Cap: CA$90.5m

Operates as an immune-oncology company in Canada.

Vext Science

Market Cap: CA$86.8m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

Decibel Cannabis

Market Cap: CA$72.1m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

NurExone Biologic

Market Cap: CA$61.6m

A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.

ZYUS Life Sciences

Market Cap: CA$55.4m

Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.

Sona Nanotech

Market Cap: CA$51.8m

Operates as a nanotechnology life sciences company.

Thiogenesis Therapeutics

Market Cap: CA$44.7m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Rubicon Organics

Market Cap: CA$41.0m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Simply Solventless Concentrates

Market Cap: CA$37.5m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

Voyageur Pharmaceuticals

Market Cap: CA$28.6m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

Charlotte's Web Holdings

Market Cap: CA$27.8m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

Cytophage Technologies

Market Cap: CA$17.6m

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

Hemostemix

Market Cap: CA$13.6m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

Innovotech

Market Cap: CA$12.0m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Marvel Biosciences

Market Cap: CA$11.3m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

MindBio Therapeutics

Market Cap: CA$6.8m

Operates as a clinical stage drug development company in Australasia.

Delivra Health Brands

Market Cap: CA$6.7m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

XORTX Therapeutics

Market Cap: CA$6.3m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

Blueberries Medical

Market Cap: CA$5.0m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

RAMM Pharma

Market Cap: CA$1.2m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.

Jolt Health

Market Cap: CA$541.0k

Operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada.

Nirvana Life Sciences

Market Cap: CA$385.9k

Engages in the research and development of therapeutic products to address addiction.

Many Bright Ideas Technologies

Market Cap: CA$258.9k

Does not have significant operations.